The Johnson & Johnson Under 40 to Watch List: 6 Young Trailblazing Scientists
SAN DIEGO, October 31, 2017 – Johnson & Johnson recently identified six young scientists working toward the next great breakthroughs in healthcare. Novoron Bioscience's CEO & President, Dr. Travis Stiles, was named one of the six. Dr. Stiles founded Novoron to develop drugs that promote regeneration of the brain and spinal cord, thus reversing the devastating consequences of nerve damage. If successful, Novoron's two current drug development focuses - a remyelination drug for multiple sclerosis and one to restore function following spinal cord injury - will result in first-in-class therapeutics for both conditions.
